175 related articles for article (PubMed ID: 25338452)
1. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
Xu BG; Xue DT; Wang XH; Yan SG
Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
[TBL] [Abstract][Full Text] [Related]
2. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.
Xue D; Zheng Q; Li H; Qian S; Zhang B; Pan Z
Int Orthop; 2011 Jan; 35(1):3-8. PubMed ID: 19830425
[TBL] [Abstract][Full Text] [Related]
3. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.
Zhu XT; Chen L; Lin JH
Medicine (Baltimore); 2018 Aug; 97(31):e11649. PubMed ID: 30075549
[TBL] [Abstract][Full Text] [Related]
4. COX-2 inhibitors for the prevention of heterotopic ossification after THA.
Vasileiadis GI; Sioutis IC; Mavrogenis AF; Vlasis K; Babis GC; Papagelopoulos PJ
Orthopedics; 2011 Jun; 34(6):467. PubMed ID: 21661680
[TBL] [Abstract][Full Text] [Related]
5. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
6. Postoperative nonsteroidal antiinflammatory drugs and the prevention of heterotopic ossification after cervical arthroplasty: analysis using CT and a minimum 2-year follow-up.
Tu TH; Wu JC; Huang WC; Chang HK; Ko CC; Fay LY; Wu CL; Cheng H
J Neurosurg Spine; 2015 May; 22(5):447-53. PubMed ID: 25723121
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.
Kan SL; Yang B; Ning GZ; Chen LX; Li YL; Gao SJ; Chen XY; Sun JC; Feng SQ
Medicine (Baltimore); 2015 May; 94(18):e828. PubMed ID: 25950691
[TBL] [Abstract][Full Text] [Related]
8. Rofecoxib inhibits heterotopic ossification after total hip arthroplasty.
van der Heide HJ; Koorevaar RC; Lemmens JA; van Kampen A; Schreurs BW
Arch Orthop Trauma Surg; 2007 Sep; 127(7):557-61. PubMed ID: 17106714
[TBL] [Abstract][Full Text] [Related]
9. Optimal strategies for the prevention of heterotopic ossification after total hip arthroplasty: A network meta-analysis.
Cai L; Wang Z; Luo X; She W; Zhang H
Int J Surg; 2019 Feb; 62():74-85. PubMed ID: 30615954
[TBL] [Abstract][Full Text] [Related]
10. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
[TBL] [Abstract][Full Text] [Related]
11. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.
Saudan M; Saudan P; Perneger T; Riand N; Keller A; Hoffmeyer P
J Bone Joint Surg Br; 2007 Feb; 89(2):155-9. PubMed ID: 17322426
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials.
Pakos EE; Ioannidis JP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):888-95. PubMed ID: 15465207
[TBL] [Abstract][Full Text] [Related]
14. Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis.
Migliorini F; Pintore A; Baroncini A; Pastor T; Hildebrand F; Maffulli N
J Orthop Traumatol; 2022 Jul; 23(1):30. PubMed ID: 35809109
[TBL] [Abstract][Full Text] [Related]
15. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis.
Shapira J; Yelton MJ; Chen JW; Rosinsky PJ; Maldonado DR; Meghpara M; Lall AC; Domb BG
Hip Int; 2022 Sep; 32(5):576-590. PubMed ID: 33736491
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
18. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
Haffer H; Müller M; Ascherl R; Perka C; Winkler T
Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
Barthel T; Baumann B; Nöth U; Eulert J
Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
[TBL] [Abstract][Full Text] [Related]
20. Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study.
Oni JK; Pinero JR; Saltzman BM; Jaffe FF
Hip Int; 2014; 24(3):256-62. PubMed ID: 24474408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
